Translational vision science & technology · 2024
Development and Validation of a Novel Night-Time Hazard Visibility Test.
СтатьяВалидационное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wood Joanne M, Lacherez Philippe, Kennon Catherine, Cuda Damian, Black Alex A
Аннотация
PURPOSE: Night-time driving is dangerous, with increased crash rates, particularly involving vulnerable road users. A Night-Time Hazard Visibility Test (NHVT) was developed and validated by exploring the effects of refractive and cataract blur on performance.
METHODS: The NHVT comprised video clips of night-time roads from the driver's perspective, including different hazards (pedestrians, cyclists, and vehicles). Participants responded when they first recognized hazards requiring them to take evasive action to avoid a collision. In experiment 1, there were 16 young visually normal drivers (mean age = 22.3, standard deviation [SD] = 2.2 years) who completed 2 NHVT sets, viewed separately through best-correction and refractive blur (+1.00 diopter sphere [DS]). In experiment 2, a refined version of the NHVT was administered to an additional 16 young visually normal drivers (mean age = 21.1, SD = 1.2 years) with best-correction and cataract blur. The order of visual conditions and NHVT sets were counterbalanced.
RESULTS: In experiment 1, refractive blur significantly reduced photopic visual acuity (VA) compared to best-corrected vision (+0.09 vs. -0.21 logMAR, P < 0.001) and delayed response times by 0.69 seconds (3.10 vs. 2.41 seconds, P < 0.001) compared to best-corrected vision. In experiment 2, cataract blur reduced VA compared to best-corrected vision (+0.03 vs. -0.17 logMAR, P < 0.001) and delayed response times by 0.63 seconds (2.92 vs. 2.29 seconds, P < 0.001).
CONCLUSIONS: The NHVT was sensitive to refractive and cataract blur, providing preliminary support of its validity as a measure of night-time hazard visibility performance.
TRANSLATIONAL RELEVANCE: The NHVT has potential as an off-road assessment of visibility for night driving and application for assessment of drivers with different refractive corrections and ocular diseases.
METHODS: The NHVT comprised video clips of night-time roads from the driver's perspective, including different hazards (pedestrians, cyclists, and vehicles). Participants responded when they first recognized hazards requiring them to take evasive action to avoid a collision. In experiment 1, there were 16 young visually normal drivers (mean age = 22.3, standard deviation [SD] = 2.2 years) who completed 2 NHVT sets, viewed separately through best-correction and refractive blur (+1.00 diopter sphere [DS]). In experiment 2, a refined version of the NHVT was administered to an additional 16 young visually normal drivers (mean age = 21.1, SD = 1.2 years) with best-correction and cataract blur. The order of visual conditions and NHVT sets were counterbalanced.
RESULTS: In experiment 1, refractive blur significantly reduced photopic visual acuity (VA) compared to best-corrected vision (+0.09 vs. -0.21 logMAR, P < 0.001) and delayed response times by 0.69 seconds (3.10 vs. 2.41 seconds, P < 0.001) compared to best-corrected vision. In experiment 2, cataract blur reduced VA compared to best-corrected vision (+0.03 vs. -0.17 logMAR, P < 0.001) and delayed response times by 0.63 seconds (2.92 vs. 2.29 seconds, P < 0.001).
CONCLUSIONS: The NHVT was sensitive to refractive and cataract blur, providing preliminary support of its validity as a measure of night-time hazard visibility performance.
TRANSLATIONAL RELEVANCE: The NHVT has potential as an off-road assessment of visibility for night driving and application for assessment of drivers with different refractive corrections and ocular diseases.